U.S. per capita healthcare spending reached $15,474 in 2024, roughly double the average in comparable developed nations. For American employers, this is the second-largest line item after wages, and it compounds. Premiums keep climbing 5 to 7 percent a year. Family coverage rose 6 percent in 2025 to an average of $26,993, with no corresponding improvement in health outcomes. Every dollar diverted to an overpriced, middleman-heavy healthcare system is a dollar that cannot fund a new production line, an R&D hire, an international expansion, or a wage increase that keeps skilled people from walking to a competitor. The cost of doing business in America now carries a healthcare surcharge that foreign rivals do not pay as employer premiums.
This puts U.S. companies at a structural disadvantage in global markets. A German manufacturer, a Japanese automaker, or a South Korean technology firm builds products with far lower health benefit overhead. The difference shows up in thinner margins for American firms, higher prices for their goods, or both. It is a matter of arithmetic. When a U.S. employer's per-worker health costs run far above a competitor's across the Pacific, that gap must come out of somewhere. Usually, it comes out of investment.
Why U.S. healthcare costs are a competitiveness problem, not just a benefits problem
Competitiveness debates often center on wages, taxes, and regulation. Healthcare gets framed as a fringe benefit to be managed, not a trade lever. That framing is outdated. In industries with tight labor markets, rising health costs directly reduce an employer's ability to offer competitive total compensation. In capital-intensive industries, they crowd out capital budgets. Over a decade of 5 to 7 percent premium growth, the cumulative drag on earnings and reinvestment becomes material enough to influence site selection, hiring plans, and acquisition strategy.
Foreign competitors operate in systems where healthcare spending is lower and more predictable. A UK-based firm pays a fraction of the employer-side health cost because the National Health Service absorbs the load. A French competitor operates under a Bismarckian system where per-capita spending is roughly half the U.S. figure. The result is a permanent cost advantage that American companies cannot close through operational tweaks alone. They need a different benefits architecture.
Foreign employers fund healthcare through payroll taxes
French and German firms do pay for healthcare, just through mandatory payroll contributions rather than premiums. France's employer social contributions are the highest in the OECD at about 27 percent of labor costs, and Germany's combined employer and employee contributions run near 40 percent of wages. A U.S. employer's 7.65 percent FICA obligation plus a family premium averaging $26,993 in 2025 does not automatically make it the higher-cost producer.
The U.S. disadvantage is the size of the total bill and what it buys. The U.S. spent $15,474 per person on healthcare in 2024, roughly double the level in comparable developed nations, and life expectancy ran about 3.7 years shorter than the comparable-country average of 82.7 years. A payment channel can be redesigned. An economy that pays twice as much for worse outcomes is a structural drag that follows every American employer into global competition.
The structural reasons costs run high
U.S. healthcare costs are not high by accident. They are high by design. Opaque pricing, pharmacy benefit manager spread pricing, insurer add-ons, and a fee-for-service model that rewards volume over outcomes all inflate the bill before a single patient walks into an exam room. An estimated 20 to 25 percent of total healthcare spend is wasted on administrative complexity, duplicative services, and pricing failures. Meanwhile, the system underinvests in the very thing that lowers long-term cost: prevention.
Only about 32 percent of Americans get an annual physical. Roughly 8 percent complete all recommended preventive care. The chronic conditions that drive the majority of employer healthcare spend (diabetes, heart disease, hypertension) are often manageable or preventable when caught early. A system that waits for sickness and then pays middlemen to process the claim guarantees rising costs. For an employer competing globally, that guarantee shows up as a permanent drag on earnings.
A structural fix that does not disrupt the existing plan
WellthCare™ was built to attack this problem at the root without requiring companies to rip out their current health plan. It works alongside an employer's existing ACA-compliant group coverage and gets used first. Employees receive $0-co-pay care, earn real, spendable reward dollars at the WellthCare Store™ for completing verified preventive actions, and build automatic retirement contributions funded by program savings. The employer does not face a new out-of-pocket cost. The system is funded through pre-tax employee elections and tax efficiencies that maintain approximately the same net take-home pay.
The mechanism changes behavior. When preventive care comes with an immediate reward and zero out-of-pocket friction, utilization climbs. When employees use WellthCare first, claims that would have hit the primary plan are reduced. The employer's claims experience improves over time, directly addressing the cost line that makes U.S. firms less competitive. And because every preventive action is verified against standardized codes and recorded in a compliance-grade system, the data is real, not self-reported.
The plan of care is AI-drafted and reviewed by a nurse practitioner and physician. It identifies health risks, recommends follow-up actions, and evolves with the member. Employees are not sent a pamphlet and told to exercise. They are given a personalized, clinical path with concrete steps and immediate economic incentives to follow it.
The compounding advantage
Small differences compound. A two-minute scan that detects an early-stage condition avoids a far larger claim years later. An employee who earns a few hundred reward dollars this year for staying current on screenings becomes a lower-cost, higher-productivity worker over the next decade. When that pattern repeats across hundreds or thousands of employees, the employer's total cost of healthcare bends downward relative to a competitor who left the status quo in place.
This is the mechanism that closes the international competitiveness gap. An American firm that reduces its healthcare cost trend by a few percentage points annually, through structural prevention rather than benefit cuts, converts a persistent liability into a smaller, more predictable line item. That frees capital for the things that drive actual competitive advantage: machinery, intellectual property, market development, and talent retention.
WellthCare also provides a Readiness Index™ after 6 to 12 months of real usage. The report shows employers, with their own claims data, exactly how much they would save by expanding the program. Nothing is sold on promises. Everything is sold on proof.
The end state is not a promise of cost certainty. No such promise exists. But a structural approach that gets used first, rewards prevention, and builds employee wealth over time does something no traditional carrier plan can do: it aligns the incentives of the employee, the employer, and the care provider toward health, not toward processing more claims.
This article is for general information only and is not legal, tax, or medical advice. Employers should consult their own advisors.